Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Marek Bednarski
KD-64 – A New Selective A2A Adenosine Receptor Antagonist Has Anti-Inflammatory Activity but Contrary to the Non-Selective Antagonist – Caffeine Does Not Reduce Diet-Induced Obesity in Mice
Related publications
(±)-Cp-96,345, a Selective Tachykinin NK1 Receptor Antagonist, Has Non-Specific Actions on Neurotransmission
British Journal of Pharmacology
Pharmacology
Potent Anti-Inflammatory and Antinociceptive Activity of the Endothelin Receptor Antagonist Bosentan in Monoarthritic Mice
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
CP-465,022, a Selective Noncompetitive AMPA Receptor Antagonist, Blocks AMPA Receptors but Is Not Neuroprotective in Vivo
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Attenuation of Ischemic Liver Injury by a Non-Selective Endothelin Receptor Antagonist
Transplantation Proceedings
Surgery
Transplantation
Corrigendum: Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 With Prominent Weight-Loss Efficacy in Diet Induced Obese Mice
Frontiers in Pharmacology
Pharmacology
Treatment of Hypertension With Ketanserin, a New Selective 5-Ht2 Receptor Antagonist.
BMJ
DPCPX, a Selective Adenosine A1 Receptor Antagonist, Enhances the Antidepressant-Like Effects of Imipramine, Escitalopram, and Reboxetine in Mice Behavioral Tests
Naunyn-Schmiedeberg's Archives of Pharmacology
Medicine
Pharmacology
Correction: Supplementation of Diet With Non-Digestible Oligosaccharides Alters the Intestinal Microbiota, but Not Arthritis Development, in IL-1 Receptor Antagonist Deficient Mice
PLoS ONE
Multidisciplinary
Effects of a Cannabinoid Receptor 2 Selective Antagonist on the Inflammatory Reaction to Titanium Particles in Vivo and in Vitro
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
